Reshma P. Shetty sold $175k of DNA
See remarks at Ginkgo Bioworks Holdings, Inc.. 26,271 shares at an average of $6.66, traded Apr 8, 2026, filed Apr 10, 2026.
Score components
- +15RoleOfficer
- +12Trade size$175k at market
- 0Share of holdings soldSold 7.2% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +38.5%, 3m +40.9%, 6m +101.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-024745, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | MOption exercise Class A Common Stockindirect: By Spouse | +27,738 | - | - | 337,101 | Apr 10, 2026 |
| Apr 8, 2026 | MOption exercise Class A Common Stockindirect: By Spouse | +27,738 | - | - | 364,839 | Apr 10, 2026 |
| Apr 8, 2026 | SOpen-market sale Class A Common Stockindirect: By Spouse | -13,155 | $6.93 | $91k | 351,684 | Apr 10, 2026 |
| Apr 9, 2026 | SOpen-market sale Class A Common Stockindirect: By Spouse | -13,116 | $6.40 | $84k | 338,568 | Apr 10, 2026 |
| Apr 7, 2026 | MOption exercise Performance-Based Restricted Stock Unitderivativeindirect: By Spouse | -27,738 | - | - | 27,738 | Apr 10, 2026 |
| Apr 8, 2026 | MOption exercise Performance-Based Restricted Stock Unitderivativeindirect: By Spouse | -27,738 | - | - | 0 | Apr 10, 2026 |
Related signals
Other insiders at Ginkgo Bioworks Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 1Weak | Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $36k 2,403 shares | -5% | |
| 26Weak | DNAsell Ginkgo Bioworks Holdings, Inc. | Christian O Henry director | $35k 5,000 shares | -21% | |
| 0Weak | DNAsell Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $2,302 330 shares | -1% | |
| 0Weak | DNAsell Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $5,943 752 shares | -1% | |
| 0Weak | DNAsell Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $2,559 307 shares | -1% | |
| 15Weak | Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $2,576 324 shares | -1% | |
| 37Weak | Ginkgo Bioworks Holdings, Inc. | Steven P. Coen See remarks | $213k 33,171 shares | -40% | |
| 39Weak | Ginkgo Bioworks Holdings, Inc. | Barry Canton owner | $802k 124,727 shares | -22% | |
| 42Moderate | Ginkgo Bioworks Holdings, Inc. | Reshma P. Shetty See remarks | $802k 124,727 shares | -22% | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | Barry Canton owner | $175k 26,271 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.